Clinical Trial

Bryophyllum Pinnatum Tea as a Novel Treatment for Recurrent Kidney Stone Formers

Enrolling by Invitation Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated May 23, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this randomized placebo-controlled double-blind crossover clinical trial is to test the ability of a traditional tea made from the leaf of the Bryophyllum pinnatum (B. pinnatum) plant in decreasing urinary calcium content in patients with recurrent calcium-based kidney stones.
Trial Details
NCT Number NCT06987084
Lead Sponsor Indra Gupta
Conditions Kidney Calculi, Calcium Oxalate Kidney Stones, Calcium Phosphate Kidney Stones
Enrollment 25 participants
Start Date 2024-11-07
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-23